Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 405
Selected: 0
NCT IDTitle
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT01745965A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.
NCT02575157Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates
NCT01583426Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)
NCT00353457Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
NCT04759248Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
NCT00391248Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)
NCT00477048Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity
NCT01321957Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
NCT04161248Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
NCT03438357Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI
NCT05825625NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
NCT03892525Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
NCT01350882Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
NCT05300282Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
NCT00201825A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients
NCT03498625Crohn's Disease Endoscopic REmission Definition in an Objective Way
NCT01059630A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
NCT02899065Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
NCT04400474Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
NCT00384566A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure
NCT00275665The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT05038657Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).
NCT02308527Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children
NCT03455582Cognition Evolution and MRI Markers in PPMS Patients on 2 Years
NCT01925820Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis B
NCT00316420Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
NCT03229382Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse
NCT00673920A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
NCT00910676Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
NCT00405860CellCept in p-ANCA Vasculitis
NCT00144976Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
NCT01439776Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
NCT03340376Doxorubicin Alone Versus Atezolizumab Alone Versus Doxorubicin and Atezolizumab in Recurrent Cervical Cancer
NCT04641676A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
NCT04993274Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT02758665Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
NCT03322865Obinutuzumab in Marginal Zone Lymphoma
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer
NCT00215982Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
NCT05918666National Register of Actionable Mutations
NCT00957866Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
NCT00544765Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer
NCT02776566Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02407080Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
NCT02064491Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
NCT03474094Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
NCT03779191Alectinib in Combination With Bevacizumab in ALK Positive NSCLC